Suz12 targets [30]; hypermethylated in grade 3 astrocytoma and grade 2 oligodendroglioma [26]; hypermethylated in low grade glioma [31]; hypermethylated in CRC [24]; low expression TF [32]. This evidence concerns the gene TF and central nervous system cancer.